June 17, 2026
SOHO Insider Hem/Onc Library Meetings / Conferences SOHO 2025 MDS News Drs. Garcia-Manero and Kantarjian discuss the phase 3 VERONA trial
GGM
MDS News SOHO 2025 Meetings / Conferences

Drs. Garcia-Manero and Kantarjian discuss the phase 3 VERONA trial

  • by
  • September 4, 2025
  • 0 Comments
  • Less than a minute
  • 1942 Views
  • 10 months ago

Guillermo Garcia-Manero, MD, and Hagop Kantarjian, MD, discuss the phase 3 VERONA trial at SOHO 2025.
Visit the SOHO 2025 meeting news page for more coverage from the meeting.

 

Share This Post:

Leave feedback about this

  • Quality
  • Price
  • Service

PROS

+
Add Field

CONS

+
Add Field

Related Post

Young scientists conducting research investigations in a medical laboratory, a researcher in the foreground is using a microscope
EHA 2026, Meetings / Conferences, Myeloproliferative Neoplasms, Primary Myelofibrosis

Novel germline JAK2 mutation linked to progression to MF in MPN

June 16, 2026
ASCO 2026, Meetings / Conferences, Myeloproliferative Neoplasms, Primary Myelofibrosis, Video Interviews

Andrew Kuykendall, MD, discusses updated data from the RALLY-MF trial

June 16, 2026
EHA 2026, Meetings / Conferences, Myeloproliferative Neoplasms, Primary Myelofibrosis

ERNEST-3 analysis characterizes prevalence of cytopenic MF and treatment trends 

June 16, 2026
EHA 2026, Meetings / Conferences, Multiple Myeloma

Study identifies new standard of care for relapsed or refractory MM in the second line and beyond

June 13, 2026
EHA 2026, ASCO 2026, Meetings / Conferences, Myeloproliferative Neoplasms

Patients with myelofibrosis and anemia respond to antihemojuvelin drug

June 12, 2026
ASCO 2026, Meetings / Conferences, Myeloproliferative Neoplasms, News

John Mascarenhas, MD, discusses the phase 3 SENTRY trial

June 11, 2026